PANAMutyper ™ EML4-ALK Screening Kit is the qualitative diagnostic test kit that is capable of detecting 16 different EML4-ALK fusion genes from non-small cell lung cancer (NSCLC) patient tissue using peptide nucleic acid (PNA) probes in a real-world fashion. time of the PCR system. The PANAMutyper ™ EML4-ALK screening kit is designed as an aid in the detection of EML4-ALK fusion-positive NSCLC patients who would be sensitive to receive ALK inhibitor therapy such as crizotinib.